
Antiviral drug firm reViral has appointed Professor Raymond 
Schinazi as a non-executive director. Schinazi has had a long and prestigious …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

